CoChat

Clinical Implications and Economic Impact of Accuracy Differences among Commercially Available Blood Glucose Monitoring Systems

Open access
Budiman, Erwin S., Samant, Navendu, Resch, Ansgar · 2013 · Journal of Diabetes Science and Technology
Cited by 30

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: Despite accuracy standards, there are performance differences among commercially available blood glucose monitoring (BGM) systems. The objective of this analysis was to assess the potential clinical and economic impact of accuracy differences of various BGM systems using a modeling approach. Methods: We simulated additional risk of hypoglycemia due to blood glucose (BG) measurement errors of five different BGM systems based on results of a real-world accuracy study, while retaining other sources of glycemic variability. Using data from published literature, we estimated an annual additional number of required medical interventions as a result of hypoglycemia. We based our calculations on patients with type 1 diabetes mellitus (T1DM) and T2DM requiring multiple daily injections (MDIs) of insulin in a U.S. health care system. We estimated additional costs attributable to treatment of severe hypoglycemic episodes resulting from BG measurement errors. Results: Results from our model predict an annual difference of approximately 296,000 severe hypoglycemic episodes from BG measurement errors for T1DM (105,000 for T2DM MDI) patients for the estimated U.S. population of 958,800 T1DM and 1,353,600 T2DM MDI patients, using the least accurate BGM system versus patients using the most accurate system in a U.S. health care system. This resulted in additional direct costs of approximately $339 million for T1DM and approximately $121 million for T2DM MDI patients per year. Conclusion: Our analysis shows that error patterns over the operating range of BGM meter may lead to relevant clinical and economic outcome differences that may not be reflected in a common accuracy metric or standard. Further research is necessary to validate the findings of this model-based approach.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/193229681300700213

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 19

  1. 10.1177/193229680900300438 · DOI · Paper page
  2. International Organization for Standardization, 2003, In vitro diagnostic test systems – requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus
  3. International Organization for Standardization, 2011, In vitro diagnostic test systems – requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus
  4. Curkendall SM, 2011, J Clin Outcomes Manage., 18, 455
  5. 10.2337/dc11-S011 · DOI · Paper page
  6. 10.1111/j.1464-5491.2010.03006.x · DOI · Paper page
  7. Bode B, 2008, Manag Care., 17, 40
  8. 10.1089/dia.2011.0170 · DOI · Paper page
  9. 10.1177/193229681100500425 · DOI
  10. 10.1089/dia.2008.0034 · DOI · Paper page
  11. Wolpert H., 2002, Smart pumping
  12. Walsh J, 2006, Pumping insulin: Everything in a book for successful use of an insulin pump
  13. Centers for Disease Control and Prevention, 2011, National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011
  14. 10.1177/193229680700100305 · DOI
  15. Hovorka R, 1993, Am J Physiol., 265, E162
  16. 10.1016/j.metabol.2004.05.014 · DOI
  17. 10.1177/193229680800200127 · DOI · Paper page
  18. 10.2337/dc06-1602 · DOI · Paper page
  19. 10.1007/978-1-4899-4541-9 · DOI · Paper page

Cited by

See all 30

Metadata

Authors
Budiman, E. S., Samant, N., & Resch, A.
Venue
Journal of Diabetes Science and Technology
Published
2013-03
Volume
7
Issue
2
Pages
365-380
ISSN
1932-2968 (ISSN-L)
OpenAlex
W1963962528
Cited by
30
References
5
FWCI
3.54
Type
journal article
Language
en
Open access
green
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Implications and Economic Impact of Accuracy Differences among Commercially Available Blood Glucose Monitoring Systems. https://app.cochat.ai/papers/10.1177/193229681300700213
The paper
Budiman, E. S., Samant, N., & Resch, A. (2013). Clinical Implications and Economic Impact of Accuracy Differences among Commercially Available Blood Glucose Monitoring Systems. Journal of Diabetes Science and Technology. https://doi.org/10.1177/193229681300700213

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.